Table of Contents Author Guidelines Submit a Manuscript
Journal of Spectroscopy
Volume 2017 (2017), Article ID 6505706, 11 pages
https://doi.org/10.1155/2017/6505706
Research Article

Spectroscopic Characterization of Omeprazole and Its Salts

1Krka d.d., Novo Mesto, Šmarješka c. 6, SI-8501 Novo Mesto, Slovenia
2National Institute of Chemistry, Hajdrihova 19, SI-1000 Ljubljana, Slovenia

Correspondence should be addressed to Jože Grdadolnik; is.ik@kinlodadrg.ezoj

Received 9 June 2017; Accepted 24 September 2017; Published 1 November 2017

Academic Editor: Yiannis Sarigiannis

Copyright © 2017 Tomislav Vrbanec et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Hickey and M. Peterson, “Novel omeprazole forms and related methods,” Patent: US 2006/0160783 A1, 2006.
  2. T. Lind, C. Cederberg, G. Ekenved, U. Haglund, and L. Olbe, “Effect of omeprazole-a gastric proton pump inhibitor-on pentagastrin stimulated acid secretion in man,” Gut, vol. 24, no. 4, pp. 270–276, 1983. View at Publisher · View at Google Scholar
  3. M. J. Kendall, “Review article: esomeprazole - the first proton pump inhibitor to be developed as an isomer,” Alimentary Pharmacology & Therapeutics, vol. 17, Supplement 1, pp. 1–4, 2003. View at Publisher · View at Google Scholar
  4. A. A. Al-Badr, “Omeprazole,” in Profiles of drug substances, excipients and related methodology, H. G. Brittain, Ed., vol. 35, pp. 151–262, Elsevier, Amsterdam, 2008. View at Google Scholar
  5. A. Gustavsson, K. Kjellbom, and I. Ymén, “Omeprazole sodium salt,” Patent: US 6.207.188 B1, 2001.
  6. M. Reddy, S. Eswaraiah, V. V. N. K. V. Raju et al., “Crystalline form C of omeprazole sodium and the related process of its preparation, a crystalline form D of omeprazole sodium and the related process of its preparation, and a process for preparation of crystalline form a of omeprazole sodium,” Patent: US 2004/0224987, 2004.
  7. L. Vranicar Savanovic, Z. Ham, and J. Rzen, “Crystalline solvate of omeprazole sodium,” Patent: US 2009/0221646, 2009.
  8. N. Markovic, S. Agntovic-Kustrin, B. Glass, and C. A. Prestidge, “Physical and thermal characterisation of chiral omeprazole sodium salts,” Journal of Pharmaceutical and Biomedical Analysis, vol. 42, no. 1, pp. 25–31, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Furuyama, S. Hasegawa, T. Hamaura et al., “Evaluation of solid dispersions on a molecular level by the Raman mapping technique,” International Journal of Pharmaceutics, vol. 361, no. 1-2, pp. 12–18, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Widjaja and R. K. Hong Seah, “Application of Raman microscopy and band-target entropy minimization to identify minor components in model pharmaceutical tablets,” Journal of Pharmaceutical and Biomedical Analysis, vol. 46, no. 2, pp. 274–281, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Clark and S. Šašić, “Chemical images: technical approaches and issues,” Cytometry Part A, vol. 69A, no. 8, pp. 815–824, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. A. E. Brändström, “Omeprazole salts,” Patent: EP 0 124 495 B1, 1987.
  13. N. H. Milac, A. Copar, B. Podobnik et al., “Crystalline form of omeprazole,” Patent: US 7.553.856 B2, 2009.
  14. N. Kumar, T. Sharma, and B. Vijayaraghavan, “Novel amorphous form of omeprazole salts,” Patent: WO 01/87831 A2, 2002.
  15. G. Kresse and J. Hafner, “Ab initio molecular dynamics for liquid metals,” Physical Review B, vol. 47, p. 558, 1993. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Kresse and J. Furthmuller, “Efficient iterative schemes for ab initio total-energy calculations using a plane-wave basis set,” Physical Review B, vol. 54, article 11169, 1996. View at Publisher · View at Google Scholar
  17. G. Kresse and D. Joubert, “From ultrasoft pseudopotentials to the projector augmented-wave method,” Physical Review B, vol. 59, p. 1758, 1999. View at Publisher · View at Google Scholar
  18. J. P. Perdew, K. Burke, and M. Ernzerhof, “Generalized gradient approximation made simple,” Physical Review Letters, vol. 77, p. 3865, 1996, Erratum Phys. Rev. Lett., vol. 78, pp. 1396, 1997. View at Publisher · View at Google Scholar
  19. H. J. Monkhorst and J. D. Pack, “Special points for Brillouin-zone integrations,” Physical Review B, vol. 13, p. 5188, 1976. View at Publisher · View at Google Scholar · View at Scopus
  20. P. M. Bhatt and G. R. Desiraju, “Tautomeric polymorphism in omeprazole,” Chemical Communications, vol. 20, pp. 2057–2059, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. D. M. Wood and A. Zunger, “A new method for diagonalising large matrices,” Journal of Physics A: Mathematical and General, vol. 18, no. 9, p. 1343, 1985. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Baroni, S. de Gironcoli, and A. del Corso, “Phonons and related crystal properties from density-functional perturbation theory,” Reviews of Modern Physics, vol. 73, p. 515, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. F. S. Murakami, A. P. Cruz, R. N. Pereira, B. R. Valente, and M. A. S. Silva, “Development and validation of a RP-HPLC method to quantify omeprazole in delayed release tablets,” Journal of Liquid Chromatography & Related Technologies, vol. 30, no. 1, pp. 113–121, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Martindale, The Complete Drug Reference, Pharmaceutical Press, London, Thomson Micromedex, Greenwood Village, 33 edition, 2002.
  25. M. Dellagreca, M. R. Iesce, L. Previtera, M. Rubino, F. Temussi, and M. Brigante, “Degradation of lansoprazole and omeprazole in the aquatic environment,” Chemosphere, vol. 63, no. 7, pp. 1087–1093, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. R. M. Claramunt, C. López, and J. Elguero, “The structure of omeprazole in the solid state: a 13C and 15N NMR/CPMAS study,” ARKIVOC, vol. 2006, no. 5, pp. 5–11, 2006. View at Publisher · View at Google Scholar
  27. M. A. Palafox, “Scaling factors for the prediction of vibrational spectra. I. Benzene molecule,” International Journal of Quantum Chemistry, vol. 77, no. 3, pp. 661–684, 2000. View at Publisher · View at Google Scholar
  28. M. A. Morsy, M. A. Al-Khalidi, and A. Suwaiyan, “Normal vibrational mode analysis and assignment of benzimidazole by ab initio and density functional calculations and polarized infrared and Raman spectroscopy,” The Journal of Physical Chemistry A, vol. 106, no. 40, pp. 9196–9203, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. P. J. Larkin, IR and Raman Spectroscopy Principles and Spectral Interpretation, Elsevier, Waltham, MA, USA, 2011.
  30. K. C. Medhi, “Vibrational spectra and thermodynamic functions of 2-methoxypyridine and 2-methoxy-d3-pyridine,” Bulletin of the Chemical Society of Japan, vol. 57, no. 1, pp. 261–266, 1984. View at Publisher · View at Google Scholar